Cargando…
Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus
Metformin is an oral hypoglycemic agent widely used in clinical practice for treatment of patients with type 2 diabetes mellitus (T2DM). The wide interindividual variability of response to metformin therapy was shown, and recently the impact of several genetic variants was reported. To assess the in...
Autores principales: | Nasykhova, Yulia A., Barbitoff, Yury A., Tonyan, Ziravard N., Danilova, Maria M., Nevzorov, Ivan A., Komandresova, Tatiana M., Mikhailova, Anastasiia A., Vasilieva, Tatiana V., Glavnova, Olga B., Yarmolinskaya, Maria I., Sluchanko, Evgenia I., Glotov, Andrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330240/ https://www.ncbi.nlm.nih.gov/pubmed/35893047 http://dx.doi.org/10.3390/genes13081310 |
Ejemplares similares
-
Overview of Transcriptomic Research on Type 2 Diabetes: Challenges and Perspectives
por: Tonyan, Ziravard N., et al.
Publicado: (2022) -
Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
por: Nasykhova, Yulia A., et al.
Publicado: (2020) -
Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021) -
Recent advances and perspectives in next generation sequencing application to the genetic research of type 2 diabetes
por: Nasykhova, Yulia A, et al.
Publicado: (2019) -
Current Status and Prospects of the Single-Cell Sequencing Technologies for Revealing the Pathogenesis of Pregnancy-Associated Disorders
por: Naydenov, Dmitry D., et al.
Publicado: (2023)